Article Category: Kd50: My Story
Publié en ligne: 21 avr. 2018
Pages: 3 - 4
DOI: https://doi.org/10.17225/jhp00048
Mots clés
© 2018
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
Use of recombinant clotting factor now represents the standard of care in haemophilia across the developed world. But the recombinant era would not have occurred without the isolation from plasma of factor VIII in sufficient quantities to allow characterisation and cloning. Much of this development work occurred at the Royal Free Hospital.